![Michael Parks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael Parks currently works at Atossa Therapeutics, Inc., as Vice President-Investor & Public Relations from 2024.
Mr. Parks also formerly worked at Centocor Johnson & Johnson, as Vice President-Corporate Communications, Liquidia Corp., as Head-Corporate Communications & Public Affairs, and PAVmed, Inc., as Vice President-Investor Relations.
Aktiva positioner av Michael Parks
| Företag | Position | Start |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Investor Relations Kontakt | 2024-08-20 |
Tidigare kända positioner av Michael Parks
| Företag | Position | Slut |
|---|---|---|
| PAVMED INC. | Investor Relations Kontakt | - |
Centocor Johnson & Johnson | Offentlig kommunikationskontakt | - |
| LIQUIDIA CORPORATION | Offentlig kommunikationskontakt | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
PAVmed, Inc.
 PAVmed, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Centocor Johnson & Johnson | |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
